Exudative bullous retinal detachment after peripheral blood stem cell transplantation

Peng, Kai Ling; Chen, S. J.; Lin, Pei Yu; Hsu, Wen-Ming; Yang, Mingjie; Tzeng, C. H.; Chen, P. M.

doi:10.1038/sj.eye.6701547

Cited by 3 publications

(2 citation statements)

References 11 publications

(9 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most of the cases manifest as rhegmatogenous retinal detachment, 76,82 but 2 cases of vision-threatening exudative bullous retinal detachment have been reported in the literature. 83 Tractional retinal detachment due to proliferative retinopathy has also been reported after HCT. 84 In one study, retinal detachment occurred in 13% patients with CMV retinitis, and the visual prognosis was often poor.…”

Section: Other Ocular Complicationsmentioning

confidence: 99%

Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT

Inamoto¹,

Petriček

Burns

et al. 2019

Bone Marrow Transplant

View full text Add to dashboard Cite

Non-graft-versus-host disease (non-GVHD) ocular complications are generally uncommon after hematopoietic cell transplantation (HCT), but can cause prolonged morbidity affecting activities of daily living and quality of life. Here we provide an expert review of non-GVHD ocular complications in a collaboration between transplant physicians and ophthalmologists through the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. Complications discussed in this review include cataracts, glaucoma, ocular infections, ocular involvement with malignancy, ischemic microvascular retinopathy, central retinal vein occlusion, retinal hemorrhage, retinal detachment and ocular toxicities associated with medications. We have summarized incidence, risk factors, screening, prevention and treatment of individual complications and generated evidence-based recommendations. Baseline ocular evaluation before HCT should be considered in all patients who undergo HCT. Follow-up evaluations should be considered according to clinical symptoms, signs and risk factors. Better preventive strategies and treatments remain to be investigated for individual ocular complications after HCT. Both transplant physicians and ophthalmologists should be knowledgeable of non-GVHD ocular complications and provide comprehensive collaborative team care.

show abstract

Section: Other Ocular Complicationsmentioning

confidence: 99%

Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT

Inamoto¹,

Petriček

Burns

et al. 2019

Bone Marrow Transplant

View full text Add to dashboard Cite

show abstract

“…It can be seen in chronic GVHD, CMV retinitis, and rarely in acute GVHD. Most cases manifest as rhegmatogenous retinal detachment [76,82], but 2 cases of vision-threatening exudative bullous retinal detachment have been reported [83]. Tractional retinal detachment due to proliferative retinopathy after HCT also has been reported [84].…”

Section: Retinal Hemorrhage and Retinal Detachmentmentioning

confidence: 99%

Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation

Inamoto¹,

Petriček

Burns

et al. 2019

Biology of Blood and Marrow Transplantation

View full text Add to dashboard Cite

Non-graft-versus-host disease (GVHD) ocular complications are generally uncommon after hematopoietic cell transplantation (HCT) but can cause prolonged morbidity affecting activities of daily living and quality of life.Here we provide an expert review of non-GVHD ocular complications in a collaboration between transplantation physicians and ophthalmologists through the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. Complications discussed in this review include cataracts, glaucoma, ocular infections, ocular involvement with malignancy, ischemic microvascular retinopathy, central retinal vein occlusion, retinal hemorrhage, retinal detachment and ocular toxicities associated with medications. We summarize the incidence, risk factors, screening, prevention, and treatment of individual complications and generate evidence-based recommendations. Baseline ocular evaluation before HCT should be considered in all patients who undergo HCT. Follow-up evaluations should be considered according to clinical signs and symptoms and risk factors. Better preventive strategies and treatments remain to be investigated for individual ocular complications after HCT. Both transplantation physicians and ophthalmologists should be knowledgeable about non-GVHD ocular complications and provide comprehensive collaborative team care.

show abstract

Isolated extramedullary ocular relapse of acute lymphoblastic leukemia after peripheral blood stem cell transplantation

GUO,

HUANG,

et al. 2013

Chinese Medical Journal

View full text Add to dashboard Cite

Exudative bullous retinal detachment after peripheral blood stem cell transplantation

Cited by 3 publications

References 11 publications

Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT

Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT

Isolated extramedullary ocular relapse of acute lymphoblastic leukemia after peripheral blood stem cell transplantation

Contact Info

Product

Resources

About